# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price tar...
Morgan Stanley analyst Kallum Titchmarsh maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and lowers the pric...
Inspire Medical Systems recalls Model 3028 IPG due to manufacturing defect causing serious health risks. Learn about the FDA Cl...
- Reuters
Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price target from $21...